Author Archives: Syndicated Content
Actor Idris Elba leads knife crime campaign with symbolic display
By Farouq Suleiman LONDON (Reuters) - Actor Idris Elba on Monday used his star power to launch a new campaign to combat knife crime in Britain, which has surged in recent years with many of the victim...
Jan 08, 2024
Lululemon raises fourth-quarter targets on steady holiday demand
(Reuters) -Lululemon raised its fourth-quarter sales and profit forecasts on Monday, in a sign that deeper discounts and deals spurred more customers to shop for the company's products during the holi...
Jan 08, 2024
Apple's Vision Pro to go on sale in February
(Reuters) - Apple said on Monday its Vision Pro mixed reality device will be available for sale from Feb. 2 in the United States. (Reporting by Akash Sriram in Bengaluru; Editing by Shinjini Ganguli)
Jan 08, 2024
Microplastics in Antarctic studied in penguin droppings and water
By Lucila Sigal BUENOS AIRES (Reuters) - The amount of microplastics in the Antarctic is being analyzed by using nuclear science to study the region's waters, sediment and even penguin droppings. The ...
Jan 08, 2024
Unseasonable rains in Ivory Coast lift cocoa outlook, farmers say
ABIDJAN (Reuters) - Unseasonable rains in most of Ivory Coast's cocoa regions last week are expected to boost both the main crop and the April-to-September mid-crop, farmers said on Monday. The world'...
Jan 08, 2024
Cellectar's blood cancer therapy succeeds in trial
(Reuters) - Cellectar Biosciences said on Monday its therapy iopofosine for Waldenstrom's macroglobulinemia, a type of blood cancer, met the main goal when tested in patients who received at least two...
Jan 08, 2024
Boston Scientific to buy Axonics for $3.7 billion
(Reuters) -Boston Scientific said on Monday it had agreed to buy medical device maker Axonics Inc for $3.7 billion. Boston Scientific will pay $71 in cash per share, representing a 23.3% premium to th...
Jan 08, 2024
J&J to buy cancer therapy developer Ambrx for $2 billion
(Reuters) -Johnson & Johnson said on Monday it had agreed to buy drug developer Ambrx Biopharma for $2 billion to gain access to its portfolio of targeted cancer therapies. J&J will pay $28 per share ...
Jan 08, 2024
Novo Nordisk says weekly IcoSema superior to daily insulin glargine, aspart
COPENHAGEN (Reuters) - Denmark's Novo Nordisk said on Monday its COMBINE 3 phase 3a drug trial had shown that a weekly injection of IcoSema was superior in controlling blood sugar level in people with...
Jan 08, 2024
Millions of plastic pellets wash up on Spanish shore
RIBEIRA, Spain (Reuters) - Hundreds of volunteers sifted through sandy beaches with colanders and shovels on Monday in Spain's northwestern Galicia region after millions of plastic pellets washed up o...
Jan 08, 2024
